The Supreme Court has refused the Trump administration’s emergency bid to restore limits on transgender treatments for federal inmates, leaving a lower-court block in place while the fight continues.
The high court on Wednesday turned away the administration’s request to stay a district court order and immediately revive Bureau of Prisons rules curbing taxpayer-funded transgender medications, treatments, and clothing that does not match biological sex. The denial came without explanation, the usual practice on the emergency docket.
The New York Post reported that Republican-appointed Justices Samuel Alito and Clarence Thomas would have granted the stay. The rest of the Court left U.S. District Judge Royce Lamberth’s ruling intact for now, so the restrictions remain on hold while the case moves forward.
The fight traces straight back to President Trump’s first day back in office. He signed an executive order aimed at restoring “biological truth to the federal government” and requiring federal agencies to treat biological sex as immutable. Earlier this year, the Bureau of Prisons followed with a program statement that stopped facilities from funding transgender medications or treatments for inmates and from letting prisoners wear outfits that do not correspond with their biological sex.
Multiple transgender inmates sued, backed by the American Civil Liberties Union. They argued the new limits violated the Eighth Amendment ban on cruel and unusual punishment. Judge Lamberth, a Reagan appointee on the U.S. District Court for the District of Columbia, sided with them and blocked the policy.
Lamberth concluded the administration had not assessed how the change would affect transgender prisoners. He also found the government had not shown the prior approach was failing on medical grounds.
In his ruling, Lamberth wrote:
"Despite providing gender-affirming care to inmates in its custody for years, the government cites in the Program Statement zero evidence from its own medical or mental health professionals to support its conclusions,"
He further held that the government offered no evidence the previous plan was “ineffective or harmful.”
An appeals court then declined the administration’s push to pause Lamberth’s order. That sent the emergency application to the Supreme Court, which left the block in place.
In court papers, the administration argued the Bureau of Prisons policy was an independent judgment call, not a simple copy of the executive order. Officials also accused Lamberth of substituting his “own policy judgment” for the Executive Branch’s.
That charge sits at the center of the dispute. The White House moved to reassert biological sex in federal rules. The prisons bureau then limited what treatments and clothing taxpayers must fund behind bars. A single district judge froze those limits nationwide for federal inmates, and higher courts have so far refused to lift the freeze on an emergency basis.
Emergency rulings often turn on the balance of harms while full appeals continue. Alito and Thomas were prepared to let the new limits take effect during that fight. The Court majority was not.
Data from the Osborne Association put the number of transgender inmates in federal prisons at just shy of 2,200 as of February of last year. Backers of the suit claim roughly 1,000 of them could lose treatment if the policy is revived.
Those figures do not settle the legal question. The inmates and the ACLU cast the limits as unconstitutional punishment. The administration cast them as a lawful return to biological sex, medical gatekeeping, and ordinary prison management. Lamberth’s order keeps the prior treatment framework in place until the courts finish the case.
Since returning to the White House in January of last year, Trump’s team has won a high share of emergency petitions at the Supreme Court. Results on the full merits have been more mixed. This application landed in the loss column on the stay question, with no written majority rationale attached.
The order does not end the litigation. It only means the Bureau of Prisons cannot enforce the contested restrictions while the appeals play out. The executive order on biological sex remains a stated administration priority. The program statement remains the policy the government wants restored. Lamberth’s findings on evidence and impact remain the barrier the Justice Department must clear or overturn.
For now, federal inmates who seek medications, treatments, or clothing tied to a gender identity at odds with biological sex continue under the older rules. Taxpayers continue to fund that status quo. Prison officials remain under a judge’s injunction rather than under the bureau’s rewritten program statement.
Alito and Thomas signaled they would have let the administration’s limits run during the appeal. The Court declined. The underlying clash over biological sex, prison medical policy, and who sets rules for federal custody is unresolved, and still headed through the courts the hard way.
When judges freeze an elected administration’s prison rules on emergency speed and keep biological reality on hold, voters should notice who is making policy, and who is not.
